Activation of nuclear factor-κB in human metastatic melanoma cells and the effect of oxidative stress

Clinical Cancer Research

Volumn 5, Issue 5, 1999, Pages 1197-1202

  Meyskens Jr , Frank L ^a   Buckmeier, Julie A ^a   McNulty, Susan E ^a   Tohidian, Niloufar B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CONTROLLED STUDY; DNA BINDING; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; MELANOMA; MELANOMA CELL; NORTHERN BLOTTING; OXIDATIVE STRESS; PRIORITY JOURNAL;

BUTHIONINE SULFOXIMINE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROGEN PEROXIDE; I-KAPPA B PROTEINS; MELANOCYTES; MELANOMA; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NF-KAPPA B; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN ISOFORMS; TRANSCRIPTION FACTOR AP-1; TUMOR CELLS, CULTURED;

EID: 0345188610     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Mastrangelo, M. J., Bellet, R. E., Kane, M. J., and Berd, D. Chemotherapy of melanoma. In: M. C. Perry (ed.), Chemotherapy Source Book, pp. 886-907. Baltimore, MD: Williams & Wilkins, 1995.
2. 6-alkylguanine-DNA-alkyl-transferase. Clin. Canc. Res., 2: 1129-1134, 1996.
3. Sharma, H. W., and Narayanan, R. The NF-κB transcription factor in oncogenesis. Anticancer Res., 16: 589-596, 1996.
4. Bauerle, P. A., and Henkel, T. Function and activation of NF-κB in the immune system. Ann. Rev. Immunol., 12: 141-179, 1994.
5. Barnes, P. J., and Karin, M. Nuclear factor-κB - a pivotal transcription factor in chronic inflammatory disease. N. Engl. J. Med., 7: 336: 1066-1072, 1997.
6. Xanthoudakis, S., and Curran, T. Redox regulation of AP-1: a link between transcription factor signaling and DNA repair. Adv. Exp. Med. Biol., 387: 69-75, 1996.
7. Sen, C. K., and Packer, L. Antioxidant and redox regulation of gene transcription. FASEB J., 10: 709-720, 1996.
8. Meyer, M., Pahl, H., and Bauerle, P. A. Regulation of the transcription factors NF-κB and AP-1 by redox changes. Chem.-Biol. Interact., 91: 91-100, 1994.
9. Pahl, H. L., and Bauerle, P. A. Oxygen and the control of gene expression. Bioessays, 16: 497-502, 1994.
10. Khan, A. U., and Wilson, T. Reactive oxygen species as cellular messengers. Chem. Biol. (Lond.), 2: 437-445, 1995.
11. Nabel, G., and Baltimore, D. An inducible transcriptional factor activates expression of human immunodeficiency virus in T cells. Nature, 326: 711-713, 1987.
12. Verma, I. M., Stevenson, S. K., Schwarz, E. M., Van Antwerp, D., and Miyamoto, S. Rel/NF-κB/IkB family: intimate tales of association and dissociation. Genes Dev., 9: 2723-2735, 1995.
13. Yamanishi, D. T., Buckmeier, J. A., and Meyskens, F. L., Jr. Expression of c-jun, jun-B and c-fos proto-oncogenes in human primary melanocytes and metastatic melanomas. J. Invest. Dermatol., 97: 349-353, 1991.
14. Prota, G. Melanins and melanogenesis. San Diego, CA: Academic Press, 1992.
15. Billingham, R. E., and Silvers, W. K. The melanocytes of mammals. Q. Rev. Biol., 35: 1-40, 1960.
16. Chedekel, M. R. Photochemistry and photobiology of epidermal melanins. Photochem. Photobiol., 35: 881-885, 1982.
17. Meyskens, F. L., Jr., Chau, H. V., Tohidian, N., and Buckmeier, J. Luminol-enhanced chemiluminescent response of human melanocytes and melanoma cells to hydrogen peroxide stress. Pigment Cell Res., 10: 184-189, 1997.
18. Picardo, M., Grammatico, P., Roccella, F., Roccella, M., Grandinetti, M., Del Porto, G., and Passi, S. Imbalance in the amioxidant pool in melanoma cells and normal melanocytes from patients with melanoma. J. Invest. Dermatol., 107: 322-326, 1996.
19. Oberly, T. D., and Oberly, L. W. Antioxidant enzyme levels in cancer. Histol. Histopathol., 12: 525-535, 1997.
20. Szatrowski, T. P., and Nathan, C. F. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res., 51: 794-798, 1991.
21. Borello, S., DeLeo, M. E., and Galeotti, T. Defective gene expression of MnSOD in cancer cells. Mol. Aspects Med. 14: 253-258, 1993.
22. Toyokuni, S., Okamoto, K., Yodoi, Y., and Hiai, H. Persistent oxidative stress in cancer. FEBS Lett., 358: 1-3, 1995.
23. Garoufalis, E., Kwan, J., Lin, R., Mustafa, A., Pepin, N., Roulston, A., Lacoste, J., and Hiscott, J. Viral induction of the human beta interferon promoter: modulation of transcription by NF-κB/rel proteins and interferon regulatory factors. J. Virol., 68: 4707-4715, 1994.
24. Rice, N. R., and Ernst, M. K. In vivo control of NF-κB activation by IkB-α. EMBO J., 12: 4685-4695, 1993.
25. Wolff, S. P. Ferrous ion oxidation in the presence of ferric ion indicator xylenol orange for measurement of hydroperoxides. Methods Enzymol., 233: 182-189, 1994.
26. Bours, V. Dejardin, E., Goujon-Letawe, F., Merville, M. P., and Castronovo, V. The NF-κB transcription, factor and cancer: high expression of NF-κB and IkB-related proteins in tumor cell lines. Biochem. Pharmacol., 47: 145-149, 1994.
27. Shattuck-Brandt, R. L., and Richmond, A. Enhanced degradation of IκB-α contributes to endogenous activation of NF-κB in Hs294T melanoma cells. Cancer Res., 14: 3032-3039, 1997.
28. Higgins, K. A., Perez, J. R., Coleman, T. A., Dorshkind, K., McLomas, W. A., Sarmiento, V. M., Rosen, C. A., and Narayanan, R. Antisense inhibition of the p65 subunit of NF-κB blocks tumorigenicity and causes tumor regression. Proc. Natl. Acad. Sci. USA, 90: 9901-9905, 1993.
29. Narayanan, R., Higgins, K. A., Perez, J. R., Coleman, T. A., and Rosen, C. A. Evidence for differential functions of the p50 and p65 subunits of NF-κB using a cell adhesion model. Mol. Cell. Biol., 13: 3802-3810, 1993.